Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M Hetland
FRI0221 Does Seropositivity Influence Differentially Drug Discontinuation of Biologic Antirheumatic Agents With Non-Anti-TNF Mode of Action?
Related publications
THU0174 Drug Retention of Tofacitinib Versus Biologic Antirheumatic Agents in Rheumatoid Arthritis: Observational Data From the Swiss SCQM Registry
Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients With Rheumatoid Arthritis
Genes
Genetics
FRI0754-HPR Impact of Corticosteroid Utilization on Biologic Disease-Modifying Antirheumatic Drug Initiation Among Patients With Rheumatoid Arthritis
Studies on the Mode of Action of Non-Steroid Anti-Inflammatory Drugs.
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
High Incidence of Disease Recurrence After Discontinuation of Disease-Modifying Antirheumatic Drug Treatment in Patients With Psoriatic Arthritis in Remission
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Site of Analgesic (Anti-Writhing) Action of a Non-Steroidal Anti-Inflammatory Drug, Tolmetin Sodium
Ensho
Editorial: Therapeutic Drug Monitoring for Anti-TNF Agents-Has It All Been Said? Author's Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Genetic Markers Predict Primary Non-Response and Durable Response to Anti-TNF Biologic Therapies in Crohn’s Disease
American Journal of Gastroenterology
Hepatology
Gastroenterology
AB1031 Anti-Drug Antibodies: Assay Performance in Patients Treated With ANTI-TNF Biodrugs
